// Regulatory Watch
Regulatory change does not announce itself to the people it obliges. Guidelines are revised, transparency rules shift, committee opinions land — and the first time many teams hear about it is a deficiency letter. Regulatory Watch is one weekly brief that reads EMA, FDA and Swissmedic so your team doesn't have to: every issue is written and judged by Carlos V. Rodriguez, 20+ years in regulatory affairs at Roche, Edwards Lifesciences and PPD/Thermo Fisher (Associate Director, RA Global Operations; Swiss legal representative for Swissmedic CTAs).
No news recycling, no press-release summaries. If it doesn't change what a regulatory team should do, know or calendar, it doesn't make the issue.
Issue #0 is free — the same format, depth and judgement as every paid issue. Read it and decide whether the Watch earns its place in your week.
Download Issue #0 (PDF, free) →For one regulatory professional. The full weekly brief, every issue, delivered to your inbox. For consultants, solo regulatory leads and anyone who is the regulatory department.
For a whole regulatory team — up to 10 readers at one company on the distribution. One subscription keeps the entire department reading from the same page.
Secure checkout by Stripe · Monthly subscription in EUR, cancel any time from your account page · Your first full issue arrives with the next weekly edition
The Watch tells you what changed. When you need the work done — a submission audited before filing, product information structured for ePI, a lay summary written, a CTIS redaction position built — our Regulatory Services do it — pricing on request — and the free Submission Readiness Checker scores your next filing in five minutes.
© 2026 Clankers.today · Regulatory Watch is a professional information service; it is not legal advice, and agency decisions remain with the agencies. Questions: support@clankers.today · Terms